Showing results (41-50 of 149) with videos related to
Sort By:
Pageof 15
Life Sciences|January 1, 1995
A "bridging" (safety/tolerance) study of besipirdine hydrochloride in patients with Alzheimer's diseaseJ J Sramek, C Viereck, F J Huff, et al.Cephalalgia : an International Journal of Headache|April 24, 1999
A double-blind, randomized, crossover assessment of blood pressure following administration of avitriptan, sumatriptan, or placebo to patients with mild to moderate hypertensionS S Jhee, D E Salazar, N F Ford, et al.Decubitus|November 1, 1993
Comparison of quantitative methodologies to define chronic pressure ulcer measurementsN R Cutler, R George, R D Seifert, et al.Clinical Pharmacokinetics|March 1, 1992
Pharmacokinetics and dose proportionality of D2-agonist MK-458 (HPMC) in parkinsonismN R Cutler, S A Reines, L F McLean, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 1, 1994
An evaluation of the anxiolytic SC 48,274 in generalized anxiety disorder (GAD)N R Cutler, J J Sramek, A E Macpherson, et al.Journal of Clinical Psychopharmacology|December 1, 1993
A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trialN R Cutler, J J Sramek, J M Keppel Hesselink, et al.Journal of Clinical Psychopharmacology|October 8, 1997
Two rapid-dose titrations of sertindole in patients with schizophreniaJ J Sramek, R J Mack, W Awni, et al.The Journal of Neuropsychiatry and Clinical Neurosciences|October 1, 1996
Assessing the neuropsychological profile of stable schizophrenic outpatientsN R Cutler, A E Veroff, E J Frackiewicz, et al.Journal of Clinical Pharmacology|October 5, 2001
Pharmacokinetic-pharmacodynamic modeling of rivastigmine, a cholinesterase inhibitor, in patients with Alzheimer's diseaseJ V Gobburu, V Tammara, L Lesko, et al.Headache|March 20, 1998
Monitoring of acute migraine attacks: placebo response and safety dataS S Jhee, D E Salazar, N F Ford, et al.Pageof 15